- Country: Ecuador
- Summary: Adalimumab 40 Mg Envelope 0.8 Ml
- ECT Ref No: 117044204
- Deadline: 21 Apr 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: USD 65000.00
- Notice Type: Tender
- Document Ref. No.: SIE-ISSFA-2025-011
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Process object: adalimumab 40 mg over 0.8 ml
Type Purchase: Well
Description: Adalimumab 40 mg over 0.8 ml
Type of contracting: Electronic reverse auction -
Total referential budget (without VAT): USD 65,000.00
Payment form: Advance: 0% Balance: Payment against delivery of goods works or service100.00%
Delivery Delivery Delivery Offers: 2025-04-09 10: 00: 00 Maximum Delivery Focus Technical Offers. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAdalimumab 40 Mg Envelope 0.8 Ml - Ecuador Tender
The ISSFA, a Government sector organization in Ecuador, has announced a new tender for Adalimumab 40 Mg Envelope 0.8 Ml. This tender is published on EcuadorTenders under ECT Ref No: 117044204 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-21.
The estimated tender value is USD 65000.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
